Drug intelligence / Profile preview

Xiao Yao Tablet

Development stage
Unknown
Lead developer
Tasly Pharmaceutical
Administration
Oral
01

Overview

Xiao Yao Tablet is a traditional herbal medicinal product (tHMP) based on the classic "Xiao Yao San" formula from Traditional Chinese Medicine (TCM). It was developed by the Tasly Group with regulatory support from SU BioMedicine and achieved a landmark registration in the Netherlands in 2021, making it one of the first TCM compound preparations to be authorized under the EU's simplified registration procedure for tHMPs. The product is indicated for the relief of mental stress and exhaustion symptoms, including nervous tension, irritability, and anxiety. The formula is a complex mixture of eight botanical ingredients, traditionally used to "soothe the liver and strengthen the spleen," which corresponds to regulating the stress response and digestive function.

Brand names
Xiao Yao Tablet
Other names
Xiao Yao WanFree and Easy WandererRambling PowderXiao Yao San
02

Targets

FXR (Farnesoid x-activated receptor)ESR1 (ERα)MAOA (Monoamine oxidase A)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))

Beyond the preview

Go deeper on Xiao Yao Tablet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiao Yao Tablet.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call